Načítá se...
Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D(2) Receptor Subtype 1
Niacin is a well established drug used to lower cholesterol and prevent cardiovascular disease events. However, niacin also causes cutaneous flushing side effects due to release of the proresolution mediator prostaglandin D(2) (PGD(2)). Recent randomized clinical trials have demonstrated that additi...
Uloženo v:
| Vydáno v: | J Pharmacol Exp Ther |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5325076/ https://ncbi.nlm.nih.gov/pubmed/28057839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.116.238261 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|